Showing results (2271-2280 of 3,105) with videos related to

Sort By:
Pageof 311
Expert Review of Anticancer Therapy|April 23, 2024
Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature reviewSuqi Zhu, Yahan Yu, Mingqi Yang, et al.
Expert Review of Anticancer Therapy|April 24, 2024
The survival effect of neoadjuvant therapy and neoadjuvant plus adjuvant therapy on pancreatic ductal adenocarcinoma patients with different TNM stages: a propensity score matching analysis based on the SEER databaseHao Hu, Yang Xu, Qiang Zhang, et al.
Expert Review of Anticancer Therapy|October 5, 2023
Selpercatinib for adult patients with locally advanced or metastatic RET-altered solid tumorsDat Le, Bhavana Konda
Expert Review of Anticancer Therapy|September 29, 2023
Immunotherapy in urothelial cancer: current status and future directionsClaudia Piombino, Elena Tonni, Marco Oltrecolli, et al.
Expert Review of Anticancer Therapy|September 26, 2023
Locoregional recurrence in triple negative breast cancer: past, present, and futureJennifer Tran, Arushi Thaper, Nerea Lopetegui-Lia, et al.
Expert Review of Anticancer Therapy|September 24, 2023
The emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecanAnna R Schreiber, Cindy L O'Bryant, Peter Kabos, et al.
Expert Review of Anticancer Therapy|October 4, 2023
Deciding individual treatment for primary retroperitoneal sarcomaDeanna Ng, Alexander Bertrand, Roberta Sanfilippo, et al.
Expert Review of Anticancer Therapy|September 21, 2024
Clinicopathological and prognostic significance of TIMP1 expression in gastric cancer: a systematic review and meta-analysisMingcan Zheng, Puxu Wang, Yuhang Wang, et al.
Expert Review of Anticancer Therapy|September 10, 2024
JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathwayJianjie Li, Xiangmei Zhang, Xueliang Liu, et al.
Expert Review of Anticancer Therapy|August 9, 2023
Inhibition of neuroactive ligand-receptor interaction pathway can enhance immunotherapy response in colon cancer: an in silico studyYun Yang, Jun Li, Chao Jing, et al.
Pageof 311